What a Philippine court ruling means for transgenic Golden Rice, once hailed as a dietary breakthrough

게시됨 2024년 5월 3일

Tridge 요약

A Philippine court has revoked a permit for the commercial planting of Golden Rice, a genetically modified rice variety developed to combat vitamin A deficiency, following a lawsuit by Greenpeace and other groups. The court's decision, which also halts new field testing, is based on the lack of scientific consensus on the safety of Golden Rice and the need for adherence to the precautionary principle. The government is expected to appeal the decision, with the process potentially taking up to two years. The ruling could impact the development of other genetically modified crops and may have broader implications beyond the Philippines.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

Golden Rice seemed to be on the cusp of fulfilling its promise. Decades ago, researchers created the genetically modified (GM) rice variety to combat vitamin A deficiency, a scourge of the developing world that can cause blindness and even lead to death. But for more than 20 years activists opposed to GM crops kept Golden Rice confined to laboratories and test plots. But in 2021, the government of the Philippines granted a permit allowing the commercial planting of Malusog Rice, a Golden Rice variety tailored for local conditions and tastes. Farmers began to grow limited amounts of the grain in 2022. Officials hoped to have the variety comprise 10% of the nation’s rice harvest within 8 years, enough to meet the needs of all vitamin A deficient households. On 17 April, however, a Philippine Court of Appeals revoked the permit, bringing that plan to a halt. Ruling on a lawsuit brought by Greenpeace and other groups, the court concluded that in the absence of a scientific consensus ...
출처: Sciencemag

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.